Cancer Researchers Testing Radical Change in Drug Trials

U C Franciso's Laura Esserman is taking a leading role in I-Spy 2, an innovative cancer trial that will rotate through up to 12 experimental cancer therapies in an effort to determine if a radical new approach can identify the right population for the right therapy on a much smaller budget.